<DOC>
	<DOCNO>NCT02274727</DOCNO>
	<brief_summary>The three-year cumulative risk recurrent stroke , dependent aetiology , 25 per cent . At present , prevent recurrence relies broad approach reduce risk factor associate atherosclerosis , heart disease metabolic disorder . However , specific intervention , anticoagulation surgery stenting , need aetiologic information . BIOSIGNAL aim determine promise biomarkers help identify stroke aetiology also predict recurrent stroke . In addition , insight gain process underlie different stroke subtypes may lead target diagnostic tool .</brief_summary>
	<brief_title>Biomarker Signature Stroke Aetiology Study : The BIOSIGNAL-Study</brief_title>
	<detailed_description>Objectives specific aim : The investigator propose prospectively evaluate predictive value promise blood biomarkers identify treatable stroke etiology admission risk recurrence 3000 consecutive ischemic stroke patient enrol 10 center Europe US . The clinical endpoint study 1 ) recurrent stroke within one year , 2 ) type atrial fibrillation ( AF ) detect admission prolong ambulatory cardiac rhythm monitor , 3 ) presence cerebrovascular atherosclerosis detect ultrasound investigation 4 ) new silent ischemic brain lesion progression chronic cerebral ischemic lesion volume detect repeated magnetic resonance imaging ( MRI MRA ) ( i.e . admission 12 month ) . Aim 1 : To determine whether proposed biomarkers independently predict recurrent stroke among patient . Hypothesis 1 : Elevated level one propose biomarkers independently predict recurrent stroke trial follow-up , assess structured interview , well chart review 90 day 1 year index stroke . Aim 2 : To determine whether cardioembolic ( CE ) biomarkers associate atrial fibrillation among patient . Hypothesis 2 : Baseline value one propose CE biomarkers independently associate AF , include history AF , AF detection baseline , AF detect follow period prolong ambulatory cardiac rhythm monitor structure interview well chart review 90 day 1 year index stroke . Aim 3 : To determine whether large artery atherosclerosis ( LAA ) biomarkers associate ) presence cerebrovascular atherosclerosis among patient . Hypothesis 3 : Baseline value one propose LAA biomarkers independently associate presence extra intracranial atherosclerosis among patient ischemic stroke , assess duplex sonography . Exploratory Aim 4 : To determine whether proposed biomarkers predict b ) new silent stroke c ) progression chronic cerebral ischemic lesion ( white matter hyper-intensity ) volume ( WMHV ) among cryptogenic stroke patient . Hypothesis 4 : Baseline value one propose biomarkers independently predict ) silent stroke b ) progression WMHV , study follow-up , assess repeat magnetic resonance imaging ( MRI ) ( admission , 1 year index stroke ) . This study conduct compliance protocol , current version Declaration Helsinki , Good Clinical Practice ( GCP ) guideline well national legal regulatory requirement .</detailed_description>
	<mesh_term>Stroke</mesh_term>
	<criteria>All consecutive patient ( age 18 ) admit suspected ischemic stroke within 24 hour symptom onset eligible . Ischemic stroke define acute localized ischemic lesion brain attributable central nervous system infection , tumor , demyelinate , degenerative neurologic disease due occlusive vascular disorder . Detailed 1 . Rapid onset focal neurologic deficit , sign symptom persist beyond 24 hour &amp; NOT associate : infection trauma tumor brain severe metabolic disorder chronic degenerative neurologic disease 2 . The development acute focal neurologic deficit persist &gt; 24 hour conjunction brain image consistent acute ischemic stroke . The CT MRI may either show new infarct change study perform entry , i.e . diagnosis clinical require CT/MRI confirmation . Secondary hemorrhagic infarction permissible . 1 . Hemorrhagic stroke 2 . All patient discharge hospital diagnosis different ischemic stroke ( i.e . stroke mimic )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Biomarker</keyword>
	<keyword>Stroke</keyword>
	<keyword>Etiology</keyword>
	<keyword>Outcome</keyword>
</DOC>